XLRN Crosses Above Average Analyst Target
November 18, 2021 at 08:56 AM EST
In recent trading, shares of Acceleron Pharma, Inc. (XLRN) have crossed above the average analyst 12-month target price of $179.30, changing hands for $179.68/share..